Speech-Language Pathologists in Las Cruces, NM Accepting Medicare

261 Speech-Language Pathologists found. Showing 1 - 20

Ms. Anna Maria Benitez Lebron, MS-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Perkins Dr, Suite B, Las Cruces, NM 88005 Phone: 575-526-6682    Fax: 575-523-7254

Lisseth Carolina Sosa Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 505 S Main St Ste 249, Las Cruces, NM 88001 Phone: 575-527-5884    Fax: 575-527-5886

Carolina Herrera, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Perkins Dr, Las Cruces, NM 88005 Phone: 505-523-7243    Fax: 505-523-7254

Ms. Elaine L Detrujillo, MA., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 505 S Main St, Suite 249, Las Cruces, NM 88001 Phone: 505-527-5823    Fax: 505-527-5886

Lissi Wandemburg Overcast, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1681 Hickory Loop, Las Cruces, NM 88005 Phone: 575-647-3773    Fax: 575-647-3777

Allison Norris, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1681 Hickory Loop, Las Cruces, NM 88005 Phone: 575-647-3773    Fax: 575-647-3777

Ms. Carol Spencer Lobato, MS., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 505 S Main St, Suite 249, Las Cruces, NM 88001 Phone: 505-527-5823    Fax: 505-527-5886

Ms. Amy Marie Mora, M.A., SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 505 S Main St Ste 249, Las Cruces, NM 88001 Phone: 575-527-5884    Fax: 575-527-5886

Susana Acosta-estrada, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 505 S Main St Ste 249, Las Cruces, NM 88001 Phone: 575-527-5884    Fax: 575-527-5886

Ms. Peggy Laverne Chacon, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Perkins Dr, Ste B, Las Cruces, NM 88005 Phone: 505-642-3583

Ms. Loree L Downing, MA., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 505 S Main St, Suite 249, Las Cruces, NM 88001 Phone: 505-527-5823    Fax: 505-527-5886

Mrs. Denise Christine Serna, MA., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 505 S Main St, Suite 249, Las Cruces, NM 88001 Phone: 505-527-5823    Fax: 505-527-5886

Breana Romero, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1350 Hillrise Cir, Las Cruces, NM 88011 Phone: 575-522-9528

Daisy Lopez, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1350 Hillrise Cir, Las Cruces, NM 88011 Phone: 575-522-9500    Fax: 575-523-1108

Mrs. Lizabeth Torres Luchini, MA., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 505 S Main St, Suite 249, Las Cruces, NM 88001 Phone: 505-527-5823    Fax: 505-527-5886

Ms. Celena Diane Tabet, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4201 Emerald St, Las Cruces, NM 88012 Phone: 575-527-9636

Sylvia Corona, MA., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 505 S Main St, Suite 249, Las Cruces, NM 88001 Phone: 505-527-5823    Fax: 505-527-5886

Marie Vigil-castillo, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Perkins Dr, Ste C, Las Cruces, NM 88005 Phone: 575-523-7243    Fax: 575-525-5641

Lydia Franziska Harrison Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 505 S Main St Ste 249, Las Cruces, NM 88001 Phone: 575-527-5884    Fax: 575-527-5886

Jeannie Rose Coon, MA-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 505 S Main St, Suite 249, Las Cruces, NM 88001 Phone: 505-527-5823    Fax: 505-527-5886

News Archive

Researchers discover small molecules that kill HPV-infected cancer cells

Researchers at The Wistar Institute announce the discovery of small molecules that kill cancer cells caused by infection with human papillomavirus (HPV). Their results, in both cell and mouse models, demonstrate that the small molecule inhibitors protect a tumor-suppressing protein targeted by viral proteins, thus killing the infected tumor cells.

Scientists identify enzyme to prevent beta-amyloids formation in Alzheimer patients

The brains of Alzheimer patients have high accumulations of the material beta-amyloid, which appear in the form of plaques. The precursors of these plaques are believed to be the underlying cause of the nerve cell loss that leads to the disruptions in memory that characterize Alzheimer's disease. The main aim of many Alzheimer therapies is therefore to inhibit the formation of beta-amyloid. Since beta-amyloid is cleaved from the so-called amyloid precursor protein (APP), scientists have focused on stopping the two enzymes that attack the precursor protein. These act like molecular scissors and cut out the beta-amyloid fragment. Blocking these scissors precludes the formation of beta-amyloid.

Hospital websites use industry-provided content and overestimate claims of surgical robots

An estimated four in 10 hospital websites in the United States publicize the use of robotic surgery, with the lion's share touting its clinical superiority despite a lack of scientific evidence that robotic surgery is any better than conventional operations, a new Johns Hopkins study finds.

NCI initiates crolibulin/cisplatin combination Phase II trial in anaplastic thyroid cancer

EpiCept Corporation today announced that the National Cancer Institute (NCI) has initiated a Phase II trial with crolibulinTM (EPC2407). The trial will assess the drug's efficacy and safety in combination with cisplatin in patients with anaplastic thyroid cancer (ATC). CrolibulinTM is a vascular disruption and apoptosis inducing agent that has demonstrated potent anti-tumor activity in both preclinical and early clinical studies.

Study suggests revolutionary way to make cancer cells more susceptible to existing chemotherapies

The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.

Read more Medical News

› Verified 8 days ago

• 1(current)
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »